Iprovalicarb Global Buyers List: A Complete Guide to Importers, Distributors, and Market Access
Iprovalicarb is a systemic fungicide developed by Bayer AG for the control of Oomycete pathogens in high-value horticultural crops. With its unique Carboxylic Acid Amide (CAA) chemistry and a market position that has historically faced limited generic competition, iprovalicarb remains a strategically important active ingredient for agrochemical buyers worldwide. This guide provides a structured overview of the global iprovalicarb buyer landscape, covering regional importers, distribution channels, procurement pathways, and the regulatory and commercial factors that shape sourcing decisions.
What Is Iprovalicarb?
Iprovalicarb (CAS 140923-17-7) is a valinamide carbamate fungicide belonging to the Carboxylic Acid Amide (CAA) group, classified under FRAC Code 40. Its IUPAC name is propan-2-yl N-[(2S)-3-methyl-1-[1-(4-methylphenyl)ethylamino]-1-oxobutan-2-yl]carbamate. The compound was first introduced to the market in 1999 and is marketed under brand names including Melody, Melody Duo, Melody Compact, Melodika, and Positon.
Iprovalicarb exhibits acropetal systemic translocation, moving upward through the plant to protect new growth. It provides protective, curative, and eradicative activity against downy mildew (Plasmopara viticola) in grapes, late blight (Phytophthora infestans) in potatoes and tomatoes, and other Oomycete diseases affecting crops such as tobacco, lettuce, onions, and cucurbits. The compound inhibits zoospore germination, mycelial growth, and sporangiophore development, making it effective across multiple stages of the pathogen life cycle.
From a toxicological perspective, iprovalicarb has a favourable profile with low acute toxicity. The oral and dermal LD50 in rats exceeds 5,000 mg/kg, and it is not classified as a reproductive toxin.
Global Regulatory Status
European Union
Iprovalicarb is an approved active substance in the European Union under Regulation (EC) No 1107/2009. Its approval was renewed by Commission Implementing Regulation (EU) 2016/147, with the current approval period extending to 31 March 2031. This long approval horizon provides regulatory certainty for buyers sourcing iprovalicarb for European markets.
United States
In the United States, the EPA has established tolerances for iprovalicarb residues on imported commodities, including grapes. This means U.S. importers of iprovalicarb-treated produce operate within a defined regulatory framework.
Other Key Markets
Iprovalicarb is registered in numerous countries across Latin America, Asia, Africa, and the Middle East. Brazil, a critical market for fungicides, has approved iprovalicarb-based products, though registration barriers remain high for new entrants. Turkey, South Africa, South Korea, Japan, and various Southeast Asian nations also maintain active registrations for iprovalicarb-containing products.
Major Change in Global Distribution Rights
The iprovalicarb buyer landscape underwent a significant shift when Dhanuka Agritech Limited, one of India’s leading agrochemical companies, acquired the international rights for manufacturing and sale of iprovalicarb and triadimenol from Bayer AG for ₹165 crore. This acquisition, completed in January 2025, grants Dhanuka access to markets in more than 20 countries across Latin America, Europe, the Middle East, Africa, and Asia.
Under the agreement, Dhanuka acquired the global rights to the Melody brand and its sub-brands, including Melody Duo, Melody Compact, and Melodika. Dhanuka plans to shift manufacturing of iprovalicarb to its Dahej facility in Gujarat, India, within two to three years to improve cost efficiency and ensure consistent global supply.
This transition has important implications for global buyers. Existing distribution relationships with Bayer are being gradually transferred to Dhanuka, and the company intends to adopt a global B2B model, collaborating with local distributors in international markets while leveraging its extensive network in India. Buyers seeking iprovalicarb should therefore monitor the transition timeline and establish direct relationships with Dhanuka’s international business development team.
Global Buyers List: Regional Breakdown
India
Dhanuka Agritech is now the primary global rights holder for iprovalicarb and serves as the central point of contact for international procurement. Domestically, iprovalicarb-based products are distributed through agricultural input retailers and wholesalers, including Samrudhi Agro Centre and Khethari Agri Tech, which supply Melody Duo formulations to Indian growers.
Europe
In Europe, iprovalicarb is sold under the Melody brand by Bayer CropScience Deutschland GmbH in Germany and Bayer CropScience S.r.l. in Italy. Parallel importers such as Star Chemicals doo and Agro Seller Discount AG facilitate cross-border distribution within the EU. The product is available in formulations including Melody Combi (iprovalicarb + folpet) and Melody Compact (iprovalicarb + copper oxychloride).
Latin America
Brazil represents a high-barrier, high-value market for iprovalicarb. Triadimenol, the companion product in the Dhanuka acquisition, holds a 20-25% market share in Brazil, and iprovalicarb commands a 50% market share with limited generic competition. Brazilian importers and distributors of iprovalicarb operate within the regulatory framework established by ANVISA and the Ministry of Agriculture. Dhanuka’s acquisition specifically targets access to this market, where entry barriers for new competitors remain substantial.
Asia-Pacific
In South Korea, iprovalicarb is registered as a mixture with zoxamide under the brand name “Jabusim,” manufactured by Hankook Samgong Co., Ltd., and used for controlling downy mildew, anthracnose, and black shank in crops including potato, onion, cucumber, tomato, grape, and watermelon. In Thailand, Bayer Thai Co., Ltd. and Chin Nong (Thailand) Co., Ltd. are registered importers and distributors of iprovalicarb-based products.
Middle East and Africa
In Turkey, iprovalicarb is registered under Bayer Türk Kimya San., with the active substance supplied by Bayer AG. In South Africa, Bayer’s Melody Duo WG 69 formulation is registered, containing iprovalicarb 90 g/kg and propineb 600 g/kg. Buyers in these regions typically source through Bayer’s regional subsidiaries or authorized distributors.
Procurement Channels and Sourcing Strategies
Direct from Rights Holder
Following the Dhanuka acquisition, the most direct procurement route for large-volume buyers is through Dhanuka Agritech’s international business division. The company has expressed its intention to operate a global B2B model, working with local distribution partners in each target market.
Authorized Regional Distributors
In markets where Dhanuka has not yet fully transitioned distribution, authorized Bayer CropScience subsidiaries and regional distributors remain active channels. European buyers can source through established parallel import frameworks, while Asian and Latin American buyers typically work through national-level agrochemical distributors.
Analytical and Reference Standards
For buyers requiring iprovalicarb analytical standards for residue testing, quality control, or research purposes, suppliers include AccuStandard, Alfa Chemistry, Santa Cruz Biotechnology, Sigma-Aldrich, and HPC Standards. These suppliers provide certified reference materials at various concentrations and pack sizes suitable for laboratory applications.
Technical Material and Formulation Procurement
Buyers seeking iprovalicarb technical material (95% minimum purity) should note that Bayer CropScience AG has historically been the primary manufacturer, though Dhanuka’s planned manufacturing transition to India will create additional supply pathways. Formulation-ready iprovalicarb is available in several combinations: with mancozeb, folpet, copper oxychloride, and fosetyl-Al plus mancozeb, offering flexibility for different crop and resistance management programs.
Market Trends and Buyer Considerations
Limited Generic Competition
One of the most notable features of the iprovalicarb market is its limited generic competition. Despite being on the market since 1999, iprovalicarb has maintained approximately 50% market share in its segment, largely due to the complexity of its synthesis and the strength of its patent and registration protections. This scarcity of generic suppliers makes iprovalicarb a premium product for buyers who require reliable, high-quality supply.
Manufacturing Shift to India
Dhanuka’s planned manufacturing transition to its Dahej facility represents a significant structural change in global iprovalicarb supply. Once operational, this facility is expected to improve cost efficiency and ensure consistent supply to meet global demand. Buyers should anticipate potential pricing adjustments and supply chain realignments as this transition progresses.
Resistance Management Demand
Iprovalicarb’s unique mechanism of action—involving inhibition of cell wall biosynthesis and amino acid metabolism—makes it a valuable tool in resistance management programs. The compound shows no cross-resistance with other fungicide classes, which drives consistent demand from growers seeking to rotate modes of action.
Formulation Innovation
The availability of multiple pre-mix formulations (with mancozeb, folpet, copper, and fosetyl-Al) allows buyers to select products tailored to specific crop and disease pressures. This formulation diversity supports demand across diverse agricultural systems, from European vineyards to Southeast Asian vegetable production.
Frequently Asked Questions
Who owns the global rights to iprovalicarb?
Dhanuka Agritech Limited acquired the international rights for manufacturing and sale of iprovalicarb from Bayer AG in January 2025. This includes the Melody brand and sub-brands, with access to over 20 countries across LATAM, EMEA, and Asia.
What is the CAS number for iprovalicarb?
The CAS number for iprovalicarb is 140923-17-7.
Which crops is iprovalicarb used on?
Iprovalicarb is used on grapes, potatoes, tomatoes, tobacco, lettuce, onions, cucumbers, and other horticultural crops for the control of downy mildew, late blight, and other Oomycete diseases.
What formulations of iprovalicarb are available?
Available formulations include combinations with mancozeb, folpet, copper oxychloride, and fosetyl-Al plus mancozeb. Branded products include Melody Duo, Melody Compact, Melody Combi, Melodika, and Positon.
Is iprovalicarb approved in the EU?
Yes. Iprovalicarb is approved in the European Union under Regulation (EC) No 1107/2009, with approval renewed by Commission Implementing Regulation (EU) 2016/147 and valid until 31 March 2031.
Where can I buy iprovalicarb analytical standards?
Analytical standards are available from suppliers including AccuStandard, Alfa Chemistry, Santa Cruz Biotechnology, and HPC Standards.
BAYER CROPSCIENCE LIMITED
GLS GLOBAL LAB SOLUTIONS PRIVATE LIMITED
CHROMATOPAK ANALYTICAL INSTRUMENTATION INDIA PVT
CÔNG TY TNHH THƯƠNG MẠI H B C
BM SCIENTIFIC PRIVATE LIMITED
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
GLOBAL LAB SOLUTIONS
ASKAR ANALYTICAL LAB SOLUTIONS PRIVATE LIMITED
BAYER PAKISTAN PRIVATE LTD
BAYER TURK KIMYA SANAYII LIMITED SIRKETI
BAYER VAPI PRIVATE LIMITED
COLE PARMER INDIA PRIVATE LIMITED
ETNA LABORATUVAR COZUMLERI SANAYI TICARET LIMITED SIRKETI
BAYER EAST AFRICA LIMITED
CEIMIC PERU SOCIEDAD ANONIMA CERRADA CEIMIC PERU S A C
CÔNG TY TNHH BAYER VIỆT NAM
CÔNG TY TNHH ĐẢM BẢO CHẤT LƯỢNG VIỆT NAM
KARUNIA JASINDO
OMC CHEMICALS AND ALLIED CHROMATOGRAPHY PRIVATE LI
PT BAYER INDONESIA
REDOKS ANALITIK CIHAZLAR ANONIM SIRKETI
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
SUMMIT AGRO ARGENTINA S A
ООО GR AGRO
ТОВ БАЙЄР 04071 М КИЇВ ВУЛ ВЕРХНІЙ ВАЛ 4Б УКРАЇНА
Conclusion
The global iprovalicarb buyer landscape is in a period of significant transition. The transfer of international rights from Bayer to Dhanuka Agritech creates new procurement pathways while preserving the product’s established brand equity and technical reputation. For buyers, the key priorities are establishing direct relationships with Dhanuka’s international division, monitoring the manufacturing transition to India, and maintaining awareness of regional registration and distribution frameworks. Given the limited generic competition and the product’s continued importance in Oomycete control programs, iprovalicarb remains a strategically valuable active ingredient for agrochemical procurement portfolios worldwide.
